×
For best experience we recommend to activate Javascript in your browser.
CTLA4 antibody (AA 52-211)
This Rabbit Polyclonal antibody specifically detects CTLA4 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for CTLA4 antibody (AA 52-211) (ABIN7615831)
Target
See all CTLA4 Antibodies
CTLA4
(Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
Reactivity
All reactivities for CTLA4 antibodies
Human
Host
All hosts for CTLA4 antibodies
Rabbit
Clonality
All clonalities for CTLA4 antibodies
Polyclonal
Conjugate
All conjugates for CTLA4 antibodies
This CTLA4 antibody is un-conjugated
Application
All applications for CTLA4 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CTLA4 Antibody
(hide)
Binding Specificity
All epitopes for CTLA4 antibodies
AA 52-211
Purpose
Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) Polyclonal Antibody
Sequence
Gly52~Cys211
Characteristics
The Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CTLA4
(hide)
Target
CTLA4
(Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
Alternative Name
CTLA4
Gene ID
1493
UniProt
P16410
Pathways
Cancer Immune Checkpoints
Recently viewed
(hide)
Chat with us , powered by LiveChat